Growth Metrics

Microbot Medical (MBOT) Cash & Current Investments (2016)

Microbot Medical's Cash & Current Investments history spans 7 years, with the latest figure at $574000.0 for Q3 2016.

  • For the quarter ending Q3 2016, Cash & Current Investments fell 97.29% year-over-year to $574000.0, compared with a TTM value of $574000.0 through Sep 2016, down 97.29%, and an annual FY2015 reading of $437000.0, changed N/A over the prior year.
  • Cash & Current Investments for Q3 2016 was $574000.0 at Microbot Medical, down from $3.1 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $32.2 million in Q3 2014, with the low at $144000.0 in Q1 2016.
  • Average Cash & Current Investments over 5 years is $16.0 million, with a median of $17.8 million recorded in 2014.
  • Year-over-year, Cash & Current Investments surged 171.57% in 2013 and then tumbled 98.98% in 2016.
  • Tracing MBOT's Cash & Current Investments over 5 years: stood at $22.4 million in 2012, then surged by 36.71% to $30.6 million in 2013, then tumbled by 97.41% to $791000.0 in 2014, then tumbled by 44.75% to $437000.0 in 2015, then skyrocketed by 31.35% to $574000.0 in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Cash & Current Investments are $574000.0 (Q3 2016), $3.1 million (Q2 2016), and $144000.0 (Q1 2016).